187 related articles for article (PubMed ID: 9817974)
21. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Murakami S; Satomi A; Ishida K; Murai H; Matsuki M; Hashimoto T
Cancer; 1994 Nov; 74(10):2745-8. PubMed ID: 7525035
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer.
Dilege E; Mihmanli M; Demir U; Ozer K; Bostanci O; Kaya C; Aksakal O; Sakiz D
Hepatogastroenterology; 2010; 57(99-100):674-7. PubMed ID: 20698248
[TBL] [Abstract][Full Text] [Related]
24. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer.
Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C
Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614
[TBL] [Abstract][Full Text] [Related]
25. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer.
He CZ; Zhang KH; Li Q; Liu XH; Hong Y; Lv NH
BMC Gastroenterol; 2013 May; 13():87. PubMed ID: 23672279
[TBL] [Abstract][Full Text] [Related]
26. Clinical Evaluation of Serum Tumor Markers in the Diagnosis of Gastric Adenocarcinoma Staging and Grading.
Ghaderi B; Moghbel H; Daneshkhah N; Babahajian A; Sheikhesmaeili F
J Gastrointest Cancer; 2019 Sep; 50(3):525-529. PubMed ID: 29806060
[TBL] [Abstract][Full Text] [Related]
27. The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases.
Wada N; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Surg Today; 2017 Feb; 47(2):227-232. PubMed ID: 27566604
[TBL] [Abstract][Full Text] [Related]
28. The use of tumor markers as predictors of prognosis in gastric cancer.
Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
[TBL] [Abstract][Full Text] [Related]
29. [The role of tumor markers in diagnosing metastases of gastric cancer: preoperative diagnostics (part I)].
Kurygin AA; Maĭstrenko NA; Khrykov GN; Beliak NP
Vestn Khir Im I I Grek; 2009; 168(4):16-9. PubMed ID: 19947409
[TBL] [Abstract][Full Text] [Related]
30. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.
Shimada H; Noie T; Ohashi M; Oba K; Takahashi Y
Gastric Cancer; 2014 Jan; 17(1):26-33. PubMed ID: 23572188
[TBL] [Abstract][Full Text] [Related]
32. Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer.
Imada T; Rino Y; Takahashi M; Hatori S; Shiozawa M; Amano T; Kondo J
Hepatogastroenterology; 1999; 46(27):2086-90. PubMed ID: 10430402
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
34. Preoperative serum CEA and CA19-9 in gastric cancer--a single tertiary hospital study of 1,075 cases.
Zhou YC; Zhao HJ; Shen LZ
Asian Pac J Cancer Prev; 2015; 16(7):2685-91. PubMed ID: 25854347
[TBL] [Abstract][Full Text] [Related]
35. Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.
Tas F; Faruk Aykan N; Aydiner A; Yasasever V; Topuz E
Am J Clin Oncol; 2001 Apr; 24(2):148-9. PubMed ID: 11319289
[TBL] [Abstract][Full Text] [Related]
36. Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients.
Takahashi I; Maehara Y; Kusumoto T; Kohnoe S; Kakeji Y; Baba H; Sugimachi K
Br J Cancer; 1994 Jan; 69(1):163-6. PubMed ID: 8286201
[TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma.
Wang W; Chen XL; Zhao SY; Xu YH; Zhang WH; Liu K; Chen XZ; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Oncotarget; 2016 Jun; 7(23):35423-36. PubMed ID: 27097114
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study.
Xiao J; Ye ZS; Wei SH; Zeng Y; Lin ZM; Wang Y; Teng WH; Chen LC
World J Gastroenterol; 2017 Dec; 23(48):8562-8569. PubMed ID: 29358864
[TBL] [Abstract][Full Text] [Related]
40. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].
Iarŭmov N; Ignatov A; Viiachki I
Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]